BCM
JNJ icon

BlueCrest Capital Management’s Johnson & Johnson JNJ Stock Holding History

BlueCrest Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-73,200
Closed -$11.6M – 174
2024
Q1 		$11.6M Sell
73,200
-24,200
-25% -$3.85M 0.57% 26
2023
Q4 		$15.3M Buy
97,400
+25,400
+35% +$3.89M 0.59% 36
2023
Q3 		$11.2M Buy
72,000
+24,800
+53% +$4.09M 0.49% 42
2023
Q2 		$7.81M Buy
+47,200
New +$7.62M 0.26% 51

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlueCrest Capital Management's JNJ Position: Q2 2024 in Review

BlueCrest Capital Management sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 10,366 shares — an estimated $1.64M sold.

BlueCrest Capital Management first reported a position in JNJ in Q2 2015 and held it in 14 quarters. The position peaked at $20.2M in Q4 2017. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • BlueCrest Capital Management reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • BlueCrest Capital Management sold 10,366 Johnson & Johnson shares in Q2 2024, an estimated $1.64M.
  • BlueCrest Capital Management first reported a position in Johnson & Johnson in Q2 2015 and held it in 14 quarters.
  • BlueCrest Capital Management's Johnson & Johnson position peaked at $20.2M in Q4 2017.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on BlueCrest Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.